Navigation Links
Diabetes drug could be a promising therapy for traumatic brain injury
Date:5/29/2012

Although the death toll is relatively low for people who suffer from traumatic brain injury (TBI), it can have severe, life-long consequences for brain function. TBI can impair a patient's mental abilities, impact memory and behavior, and lead to dramatic personality changes. And long-term medical treatment carries a high economic cost.

Now, in research commissioned by the United States Air Force, Prof. Chaim Pick of Tel Aviv University's Sackler Faculty of Medicine and Dr. Nigel Greig of the National Institute of Aging in the US have discovered that Exendin-4, an FDA-approved diabetes drug, significantly minimizes damage in TBI animal models when administered shortly after the initial incident. Originally designed to control sugar levels in the body, the drug has recently been found effective in protecting neurons in disorders such as Alzheimer's disease.

Prof. Pick's collaborators include his TAU colleagues Dr. Vardit Rubovitch, Lital Rachmany-Raber, and Prof. Shaul Schreiber, and Dr. David Tweedie of the National Institute of Aging in the US. Detailed in the journal Experimental Neurology, this breakthrough is the first step towards developing a cocktail of medications to prevent as much brain damage as possible following injury.

Diabetes medication to halt trauma

Prof. Pick has been researching TBI for many years, beginning with the effects of everyday injuries such as hitting the windshield in a car accident. As a result of his work for the Air Force, he has expanded his research to include trauma sustained when a person is exposed to an explosion, such as during a terrorist attack.

TBI causes long-term damage by changing the chemistry of the brain. During an explosion, increased pressure followed by an intense vacuum shakes the fluid inside the brain and damages the brain's structure. This damage cannot be reversed, but mapping the injury through behavioral and physical tests is crucial to understanding and quantifying the damage and forming a treatment plan through therapy or medication.

Prof. Pick and his colleagues designed a pre-clinical experiment that exposed mice to controlled explosions from 23 and 33 feet away, and then analyzed the resulting injuries. They also studied the effect of Exendin-4 as an additional parameter in minimizing brain damage.

The researchers divided their mice into four groups: a control group; a second group that was exposed to the blast without medication; a third group that received the medication but was not exposed to the blast; and a fourth group, exposed to the explosion but given the medication within an hour after the blast and continuing for seven days afterwards. The mice were placed under anaesthesia before the explosion.

Behavioral and physical tests showed that the mice that had been exposed to the blast had severely impaired brain function compared to the control group. However, the mice that had also received the Exendin-4 treatment were almost on a par with the control group in terms of brain function, proving that Exendin-4 significantly reduced the long-term damage done by an explosion. In separate experiments, the drug was also associated with an improved outcome in mice who sustained TBI by blunt force.

Finding the ideal drug cocktail

Prof. Pick says this promising discovery can help researchers find the ideal combination of medications to minimize the lasting impact of TBI. "We are moving in the right direction. Now we need to find the right dosage and delivery system, then build a cocktail of drugs that will increase the therapeutic value of this concept," he explains. He adds that in treating such traumatic injuries, one drug is unlikely to be sufficient.

This work was also done in collaboration with Dr. Bruce Citron from the American Veterans Association and Dr. Barry Hoffer from the National Institute of Drug Abuse at the National Institute of Health.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Related medicine news :

1. 1 size doesnt fit all when treating blood pressure in people with diabetes, VA/U-M study suggests
2. Aggressively controlling glucose levels may not reduce kidney failure in Type 2 diabetes
3. Phone contact with nurses linked with better outcomes for women with gestational diabetes
4. U.S. Sees Drop in Deaths Linked to Diabetes
5. Diabetes Can Take a Toll on Your Emotions
6. New inflammation hormone link may pave way to study new drugs for Type 2 diabetes
7. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
8. Eye Changes May Predict Heart Disease in Blacks With Diabetes
9. Oxygen Therapy Slows Type 1 Diabetes in Mice, Study Says
10. Southeast program to fight diabetes awarded nearly $10 million by HHS
11. Unique physiology key to diagnosing and treating diabetes in Asian populations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... Certemy, a leading provider of ... of new features for custom branding. The new features allow customers to customize ... physical brand attributes. Customizable attributes include customer logo, an optional vanity URL, brand-specific ...
(Date:11/11/2019)... (PRWEB) , ... November 11, 2019 , ... Last year’s ... 46 different countries including big box buyers like Costco, Walmart, and GNC. Exhibitors ... GRN to name a few. , This year, CBD.io and partners, ...
(Date:11/9/2019)... ... 08, 2019 , ... The Women’s Dermatologic Society (WDS) announced that Marta I. ... Board of Directors appointed Molly Hinshaw, MD to fill the remainder of Dr. Rendon’s ... term and will be presented to the membership as the 2020-2021 President at the ...
(Date:11/7/2019)... ... November 06, 2019 , ... An October 13 article on ... According to the article, while no U.S. state had an obesity rate above 15 ... percent obese. The article cites quite a few reasons for this rise, including eating ...
(Date:11/7/2019)... , ... November 07, 2019 , ... ... co-founder of Ignite and Expand got together on the Shamangelic Healing Podcast ... of downloads skyrocketed. With a trending focus on learning ways to use bio-hacking ...
Breaking Medicine News(10 mins):
(Date:11/6/2019)... ... 2019 , ... Doral Health & Wellness, a multispecialty, interdisciplinary ... Center on Pitkin Avenue in the Brownsville section of Brooklyn. , The beautifully ... diabetes. Seniors can take part in fitness and meditation classes, art and music ...
(Date:11/6/2019)... ... November 06, 2019 , ... Dutch Bros Coffee raised $333,360 for ... Month. $10 from each “Be Aware” mug sold in October was donated to patient ... opportunity to help support these amazing organizations,” said Travis Boersma, CEO and co-founder of ...
(Date:11/6/2019)... ... 2019 , ... Regen Suppliers is now offering a first ... all others on the market including extremely high particle counts, and Regen Suppliers ... more information and ordering. , As a comprehensive distributor of regenerative products and ...
Breaking Medicine Technology: